Short Interest in Catheter Precision, Inc. (NYSEAMERICAN:VTAK) Rises By 100.3%

Catheter Precision, Inc. (NYSEAMERICAN:VTAK) was the recipient of a significant increase in short interest in August. As of August 31st, there was short interest totalling 172,900 shares, an increase of 100.3% from the August 15th total of 86,300 shares. Currently, 14.5% of the shares of the stock are sold short. Based on an average daily volume of 151,600 shares, the short-interest ratio is presently 1.1 days.

Catheter Precision Price Performance

NYSEAMERICAN VTAK traded up $0.01 on Friday, reaching $0.43. The company’s stock had a trading volume of 156,530 shares, compared to its average volume of 60,289. Catheter Precision has a twelve month low of $0.38 and a twelve month high of $8.40.

Catheter Precision (NYSEAMERICAN:VTAK) last issued its earnings results on Wednesday, August 14th. The company reported ($5.57) earnings per share (EPS) for the quarter. Catheter Precision had a negative return on equity of 50.02% and a negative net margin of 2,176.83%. The company had revenue of $0.09 million during the quarter. Equities analysts predict that Catheter Precision will post -8.7 earnings per share for the current fiscal year.

About Catheter Precision

Catheter Precision, Inc designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company’s lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures.